CHI3L1 and Alzheimer disease: Another study confirmed these results showing that the YKL-40 levels were increased in the CSF of MCI-AD patients compared to those with stable MCI; therefore, authors suggested that this protein could represent a potential prognostic biomarker for the progression of MCI to clinical AD [37].